Azlocillin: In Vitro Studies of a New Semisynthetic Penicillin

AUTOR(ES)

Stewart, Dorothy

RESUMO

The activity of azlocillin, a new semisynthetic penicillin, was determined against 582 clinical isolates of gram-negative bacilli and gram-positive cocci. Over 75% of the isolates of Pseudomonas aeruginosa were inhibited at a concentration of 12.5 μg or less per ml. Azlocillin is also active against indole-negative and -positive Proteus spp., inhibiting 98 and 71%, respectively, at a concentration of 12.5 μg or less per ml. Isolates of Klebsiella spp. and Enterobacter spp. showed less susceptibility than isolates of Escherichia coli and Serratia spp. Gram-positive cocci except penicillin G-resistant Staphylococcus aureus were susceptible to azlocillin. Azlocillin failed to inhibit the growth of gram-negative bacilli when large inocula were used. It was more active in alkaline pH, but the type of medium used had little effect on its activity. Azlocillin was more active than mezlocillin, ticarcillin, and carbenicillin and as active as BLP-1654 against isolates of P. aeruginosa. It was not as active as mezlocillin against the majority of the other gram-negative bacilli.

Documentos Relacionados

• In Vitro Studies of Piperacillin, a New Semisynthetic Penicillin
• CI-867, a new semisynthetic penicillin: in vitro studies.
• In Vitro Studies of α-Carboxyl-3-Thienylmethyl Penicillin, a New Semisynthetic Penicillin
• In Vitro Studies of a New Semisynthetic Penicillin, 6-(D-α-Sulfoaminophenylacetamido)-Penicillanic Acid1
• In vitro activity of BRL 36650, a new semisynthetic penicillin.